Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: Receptor-stimulated GTPase and evaluation of agonists and partial agonists

Molecular Pharmacology

Volumn 49, Issue 1, 1996, Pages 190-197

  Seiler, Steven M ^a   Peluso, Marianne ^a   Tuttle, Jeffrey G ^a   Pryor, Kelly ^a   Klimas, Clifford ^a   Matsueda, Gary R ^a   Bernatowicz, Michael S ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE; N ETHYLMALEIMIDE; PERTUSSIS TOXIN; THROMBIN; THROMBIN RECEPTOR; THROMBIN RECEPTOR ACTIVATING PEPTIDE;

ARTICLE; DRUG POTENCY; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR OCCUPANCY; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE;

AMINO ACID SEQUENCE; ANTIBODIES; BLOOD PLATELETS; CELL LINE; CELL MEMBRANE; ENZYME ACTIVATION; ETHYLMALEIMIDE; GTP PHOSPHOHYDROLASES; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDES; PERTUSSIS TOXIN; RECEPTORS, THROMBIN; THROMBIN; VIRULENCE FACTORS, BORDETELLA;

EID: 0030023688     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Coughlin, S. R. Thrombin receptor function and cardiovascular disease. Trends Cardiavasc. Med. 4:77-83 (1994).
2. Vu, T.-K. H., D. T. Hung, V. I. Wheaton, and S. R. Coughlin. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64:1057-1068 (1991).
3. 2+ mobilization. FEBS Lett. 288:123-128 (1991).
4. Bahou, W. F., B. S. Coller, C. L. Potter, K. J. Norton, J. L. Kutok, and M. S. Goligorsky. The thrombin receptor extracellular domain contains sites crucial for peptide ligand-induced activation. J. Clin. Invest. 91:1405-1413 (1993).
5. Zhong, C., D. J. Hayzer, M. A. Corson, and M. S. Runge. Molecular cloning of the rat vascular smooth muscle thrombin receptor: evidence for in vioo regulation by basic fibroblast growth factor. J. Biol. Chem. 267:16975-16979 (1992).
6. Hoxie, J. A., M. Ahuja, E. Belmonte, S. Pizarro, R. Parton, and L. F. Brass. Internalization and recycling of activated thrombin receptors. J. Biol. Chem. 268:13756-13763 (1993).
7. Scarborough, R. M., M. A. Naughton, W. Teng, D. T. Hung, J. W. Rose, T.-K. H. Vu, V. I. Wheaton, C. W. Turck, and S. R. Coughlin. Tethered ligand agonist peptides: structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function. J. Biol. Chem. 267:13146-13149 (1992).
8. Natarajan, S., D. Riexinger, M. Peluso, and S. Seiler. Tethered ligand derived penta peptide agonists of thrombin receptor: a study of side chain requirements for platelet activation. Int. J. Peptide Protein. Res. 45:145-151 (1995).
9. Hung, D. T., Y. H. Wong, T.-K. H. Vu, and S. R. Coughlin. The cloned platelet thrombin receptor couples to at least two distinct effectors to stimulate phosphoinositide hydrolysis and inhibit adenylyl cyclase. J. Biol. Chem. 267:20831-20834 (1992).
10. 12. J. Cell Biol. 121:91-99 (1993).
11. 2 and thrombin receptors in human platelets. Proc. Natl. Acad. Sci. USA 91:504-508 (1994).
12. αq family. FEBS Lett. 363:49-52 (1995).
13. Baffy, G., L. Yang, S. Raj, D. R. Manning, and J. R. Williamson. G protein coupling to the thrombin receptor in Chinese hamster lung fibroblasts. J. Biol. Chem. 269:8483-8487 (1994).
14. Brass, L. F., M. Ahuja, E. Belmonte, S. Pizarro, A. Tarver, and J. A. Hoxie. The human platelet thrombin receptor: turning it on and turning it off. Ann. N. Y. Acad. Sci. 714:1-12 (1994).
15. Kinlough-Rathbone, R. L., D. W. Perry, M. A. Guccione, M. L. Rand, and M. A. Packman. Degranulation of the human platelets by the thrombin receptor peptide SFLLRN: comparison with degranulation by thrombin. Thromb. Haemost. 70:1091-1023 (1994).
16. + exchange by a thrombin receptor antagonist. Biochem. Pharm. 49:519-528 (1995).
17. Huang, R.-S., A. Sorisky, W. R. Church, E. R Simons, and S. E. Rittenhouse. Thrombin receptor-directed ligand accounts for activation by thrombin of platelet phospholipase C and accumulation of 3-phosphorylated phosphoinositides. J. Biol. Chem. 266:18435-18438 (1991).
18. Seiler, S. M., I. M. Michel, and J. W. Fenton II. Involvement of the tethered-ligand receptor in thrombin inhibition of platelet adenylate cyclase. Biochem. Biophys. Res. Commun. 182:1296-1302 (1992).
19. Vassallo, R. R. J., T. Kieber-Emmons, K. Cichowski, and L. F Brass. Structure-function relationships in the activation of platelet thrombin receptors by receptor-derived peptides. J. Biol. Chem. 267:6081-6085 (1992).
20. Pumiglia, K. M., and M. B. Feinstein. Thrombin and thrombin receptor agonist peptide induce tyrosine phosphorylation and tyrosine kinases in the platelet cytoskeleton. Biochem. J. 294:253-260 (1993).
21. Lau, L -F., K. Pumigha, Y. P. Côté, and M. Feinstein. Thrombin-receptor agonist peptides, in contrast to thrombin itself, are not full agonists for activation and signal transduction in human platelets in the absence of platelet-derived secondary mediators. Biochem. J. 303:391-400 (1994).
22. Brass, L. F., R. R. J. Vassallo, E. Belmonte, M. Ahuja, K. Cichowski, and J. A. Hoxie. Structure and function of the human platelet thrombin receptor: studies using monoclonal antibodies directed against a defined domain within the receptor N terminus. J Biol. Chem. 267:13795-13798 (1992).
23. Hung, D. T., T.-K. H. Vu, V. I. Wheaton, K. Ishii, and S. R. Coughlin. Cloned platelet thrombin receptor is necessary for thrombin-induced platelet activation. J. Clin. Invest. 89:1350-1353 (1992).
24. Tapparelli, C., R. Metternich, and N. S. Cook. Structure and function of thrombin receptors. Trend. Pharmacol. Sci. 14:426-428 (1993).
25. Kinlough-Rathbone, R. L., M. L. Rana, and M. A. Packman. Rabbit and rat platelet do not respond to thrombin receptor peptides that activate human platelets. Blood 82:103-106 (1993).
26. Connolly, T. M., C. Condra, D.-M. Feng, J. J. Cook, M. T. Stranieri, C. F. Reilly, R. F. Nutt, and R. J. Gould. Species variability in platelet and other cellular responsiveness to thrombin receptor-derived peptides. Thromb. Haemost. 72:627-633 (1994)
27. Grandt, R., K. Aktories, and K. H. Jakobs, Evidence for two GTPases activated by thrombin in membranes of human platelets. Biochem. J. 237:669-674 (1986).
28. Houslay, M., D. Bojanic, S. O'Hagan, and A. Wilson, Thrombin, unlike vasopressin, appears to stimulate two distinct guanine nucleotide regulatory proteins in human platelets. Biochem. J. 238:109-113 (1986).
29. Bradford, M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254 (1976).
30. q family. J. Biol. Chem 266:9309-9313 (1991).
31. Katada, T., J. K. Northup, G. M. Bokoch, M. Ui, and A. Gilman. The inhibitory guanine nucleotide-binding regulatory component of adenylate cyclase. J. Biol. Chem. 259:3568-3577 (1984).
32. Bernatowicz, M. S., and G. R. Matsueda. Preparation of peptide-protein immunogens using N-succinimidyl bromoacetate as a heterobifunctional crosslinking reagent. Anal. Biochem. 155:95-102 (1986).
33. Bajusz, S., E. Szell, D. Bagdy, E Barabas, G. Horvath, M. Dioszegi, Z. Fittler, G. Szabo, A. Juhasz, E. Tomori, and G. Szilagyi. Highly active and selective anticoagulants: D-Phe-Pro-Arg-H, a free tripeptide aldehyde prone to spontaneous Inactivation, and its stable N-methyl derivative, D-MePhe-Pro-Arg-H. J. Med. Chem. 33:1729-1735 (1990).
34. Seiler, S. M., H. J. Goldenberg, I. M. Michel, J. T. Hunt, and G. B. Zavoico. Multiple pathways of thrombin-induced platelet activation differentiated by peptide desensitization and by thrombin exosite inhibitors. Biochem. Biophys Res. Commun. 181:636-643 (1991).
35. Rasmussen, U. B., C. Gachet, Y. Schlesinger, D. Hanau, P. Ohlmann, E. Van Obberghen-Schilling, J. Pouyssegur, J.-P. Cazenave, and A. Pavirani. A peptide ligand of the human thrombin receptor antagonizes thrombin and partially activates platelets. J. Biol. Chem 268:14322-14328 (1993).
36. Brass, L. F., J. A., Hoxie, and D. R. Manning. Signaling through G proteins and G protein-coupled receptors during platelet activation. Thromb. Haemost. 70:217-223 (1993).
37. 1. J. Biol. Chem. 261:16838-16847 (1986).
38. Wilhelm, B., and W. Siess. Activation of the cloned platelet thrombin receptor decreases the pertussis-toxin-dependent ADP-ribosylation of the membrane and soluble inhibitory guanine-nucleotide-binding-α proteins: inhibition by the prostacyclin analog, iloprost. Eur. J. Biochem. 216:81-88 (1993).
39. Brass, L. F. Homologous desensitization of HEL cell thrombin receptors: distinguishable roles for proteolysis and phosphorylation J. Biol. Chem. 267:6044-6050 (1992).
40. Vouret-Craviari, V., D. Grall, J.-C. Chambard, U. B. Rasmussen, J. Pouyssegur, and E. Van Obberghen-Schilling. Post-translational and activation-dependent modifications of the G protein-coupled thrombin receptor. J. Biol. Chem. 270:8367-8372 (1995).
41. Molino, M., N. Blanchard, E. Belmonte, A. P. Tarver, C. Abrams, J. A. Hoxi, C. Cerletti, and L. F. Brass. Proteolysis of the human platelet and endothelial cell thrombin receptor by neutrophil-derived cathepsin G. J. Biol. Chem. 270:11168-11175 (1995).
42. Nose, T., Y. Shimohigashi, M. Ohno, T. Costa, N. Shimizu, and Y. Ogino. Enhancement of thrombin receptor activation by thrombin receptor-derived heptapeptide with para-fluorophenylalanine in place of phenylal-anine. Biochem. Biophys. Res. Commun. 193:694-699 (1993).
43. Kenikin, T. Pharmacologic Analysis of Drug-Receptor Interaction, Ed. 2. Raven Press, New York, 1993.